Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0319521 EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF
Compositions for reducing the frequency of urination and methods of manufacturing the compositions are disclosed. The compositions comprises a first component...
2017/0319520 EXTENDED, DELAYED AND IMMEDIATE RELEASE FORMULATION METHOD OF MANUFACTURING AND USE THEREOF
Compositions for reducing the frequency of urination and methods of manufacturing the compositions are disclosed. The compositions comprises a first component...
2017/0319519 COMBINATION FOR THE TREATMENT OF CONDITIONS INVOLVING MUSCULAR PAIN
The present invention is related to a combination comprising a COX inhibitor, a Mg.sup.2+ source, and ascorbic acid or a stereoisomer or a pharmaceutically...
2017/0319518 Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen
Sodium ibuprofen compositions and methods of manufacturing tablets and caplets comprising sodium ibuprofen are described. The formulation is advantageous...
2017/0319517 METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITIS
The invention features a method for inhibiting one or more voltage-gated ion channels in a cell by contacting the cell with (i) a first compound that activates...
2017/0319516 NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER
2-hydroxy-benzoic anilide compounds and derivatives, compositions thereof, and methods for treating metabolic diseases and cancer through uncoupling mitochondria.
2017/0319515 OPHTHALMIC COMPOSITIONS
Provided herein is an ophthalmic composition including a therapeutic active agent and an anti-inflammatory agent, in which the active agent is at least about...
2017/0319514 DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.
2017/0319513 DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.
2017/0319512 DELAYED RELEASE CYSTEAMINE BEAD FORMULATION, AND METHODS OF MAKING AND USING SAME
An enteric-coated bead dosage form of cysteamine, and related methods of manufacture and use, are disclosed.
2017/0319511 COMPOSITIONS FOR OVERCOMING RESISTANCE TO TRAMADOL
Disclosed herein is a composition for oral administration of O-desmethyltramadol that is effective for overcoming resistance to tramadol in patients.
2017/0319510 METHODS FOR OVERCOMING RESISTANCE TO TRAMADOL
There is disclosed a method for treating disorders modulated by at least opiate receptor activity or monoamine activity, including acute and chronic pain,...
2017/0319509 COMPOSITION BASED ON COQ10
Ternary composition of CoQ10, one or more specific hydroxypropylcellulose (HPC) based amphiphilic carriers and one or more adjuvants selected from the group of...
2017/0319508 CURCUPHENOL COMPOUNDS FOR INCREASING MHC-I EXPRESSION
Provided are methods of using curcuphenol compounds to increase expression of major histocompatibility complex class I (MHC-I) antigen in cells, particularly...
2017/0319507 CROSSLINKED NANOPARTICLE COMPOSITION
The present invention provides a process for preparing the nanoparticles. The process comprises first forming a water-in-oil emulsion from chitosan lactate,...
2017/0319506 SHEAR-THINNING SELF-HEALING NETWORKS
Network materials which exhibit both shear thinning and self-healing properties are disclosed. The networks contain particles and gel-forming compounds. The...
2017/0319505 SUSTAINED RELEASE ENCAPSULATED NANOPARTICLES
The present invention provides a microparticle comprising at least one biocompatible polymer, the microparticle encapsulating at least one nanoparticle, the...
2017/0319504 STATIN-ENCAPSULATED NANOPARTICLE PREPARATION FOR ENHANCING STEM CELL FUNCTION, STEM CELL WITH ENHANCED FUNCTION...
The present invention is a preparation containing a statin-encapsulated nanoparticle obtained by encapsulating statin in a nanoparticle containing a...
2017/0319503 ENCAPSULATION OF AN OIL CONTAINING UNSATURATED FATTY ACIDS
The present invention provides microcapsules in which oil comprising unsaturated fatty acids is encapsulated, such as polyunsaturated fatty acids (PUFAs), the...
2017/0319501 Oral Pharmaceutical Dosage Forms
Abuse-resistant oral dosage forms suitable for administration of pharmacologically active agents are provided.
2017/0319500 SELF-ASSEMBLED GELS FOR CONTROLLED DELIVERY OF BIOLOGICS AND LABILE AGENTS
Gels are formed based on generally recognized as safe (GRAS) low molecular weight amphiphilic molecules in a self-assembly process with limited or no heating....
2017/0319499 SELF ASSEMBLED GELS FOR CONTROLLED DELIVERY OF ENCAPSULATED AGENTS TO CARTILAGE
A self-assembled gel composition with enhanced adhesion to cartilage tissue is provided. A cationic agent co-self assembles with a generally regarded as safe...
2017/0319498 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319497 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319496 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319495 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319494 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319493 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319492 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319491 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319490 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319489 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319488 TAMPER RESISTANT DOSAGE FORMS
The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of...
2017/0319487 SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR
This invention relates to sustained release dosage forms comprising {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H- ...
2017/0319486 TWIN-SCREW DRY GRANULATION FOR PRODUCING SOLID FORMULATIONS
A dry granulation process using a twin-screw extruder for granulating a powder mixture which includes at least one active ingredient and at least one carrier....
2017/0319485 IN VIVO STEALTH NANOPARTICLE
Provided is a molecular imprint polymer that is capable of acquiring stealth properties through a new mechanism. The molecular imprint polymer according to the...
2017/0319484 DICLOFENAC FORMULATIONS AND METHODS OF USE
Methods and formulations are provided for treating migraine and other acute pain episodes using diclofenac, and formulations of diclofenac that provide both...
2017/0319483 METHOD FOR PRODUCING POROUS PARTICLE
A method for producing porous particles includes (1) a step of preparing a solution of an amphiphilic substance by dissolving the amphiphilic substance in a...
2017/0319482 TARGETED LIPOSOMAL GEMCITABINE COMPOSITIONS AND METHODS THEREOF
This disclosure relates to a targeted PEGylated liposomal gemcitabine (PLG) composition comprising a PEGylated liposome encapsulating one or more agents...
2017/0319481 A DISCONTINUOUS REVERSE MICELLAR COMPOSITION IN CUBIC FD3M PHASE FOR SUSTAINED RELEASE OF THERAPEUTIC DRUGS
The present invention discloses reverse/inverse micellar discontinuous cubic phase (Fd3m phase) composition for controlled release of therapeutic drugs or...
2017/0319480 PHARMACEUTICAL FORMULATION
The present invention relates to pharmaceutical formulations of highly active drugs with limited shelf-life in aqueous media, suitable to be administered by a...
2017/0319479 ENHANCED STABILITY OF NOVEL LIQUID COMPOSITIONS
The present invention relates to compositions of pharmaceutical agents in combination with additional pharmaceutical agents in a mixture of polyethylene...
2017/0319478 Excipient Suitable for Preparing Creams
An excipient, suitable for the preparation of pharmaceutical and/or cosmetic creams comprises an aqueous phase and organic phase comprising organic components....
2017/0319477 INGESTIBLE FORMULATIONS FOR TRANSIENT, NONINVASIVE REDUCTION OF GASTRIC VOLUME
Provided are ingestible polymeric formulations for the reduction of gastric volume in the treatment of overweight patients, and methods of use thereof. One...
2017/0319476 Floating Zinc Gastric Delivery Compositions
A composition includes a therapeutically effective oral pharmaceutical dosage form that becomes buoyant upon contact with gastric fluid. The dosage form...
2017/0319475 Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor...
The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use...
2017/0319474 OPHTHALMIC DEVICE HAVING THERAPEUTIC AGENT DELIVERY CAPABILITY AND METHOD OF FORMING SAME
The present invention is directed to ophthalmic devices that are loaded with therapeutic agent. The devices provide prolonged release of the therapeutic agent...
2017/0319473 TEAT PACK MATERIAL FOR LACTATING LIVESTOCK, KIT FOR FORMING TEAT PACK FOR LACTATING LIVESTOCK, AND METHOD FOR...
A teat protective pack material for coating teats of lactating livestock to prevent mastitis is disclosed, the teat protective pack material including a...
2017/0319472 IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER
The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions...
2017/0319471 METHOD FOR THE PRODUCTION OF A SODIUM ION-FREE EFFERVESCENT TABLET, POWDER OR GRANULATE HAVING A HIGH X ION...
The process serves for preparing sodium ion-free X carbonate or hydrogencarbonate effervescent powder, such granules or such tablets. The active substances X,...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.